Detalles de la búsqueda
1.
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study).
Br J Cancer
; 105(8): 1123-30, 2011 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21934690
2.
An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study.
Crit Rev Oncol Hematol
; 64(1): 73-81, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17669664
3.
Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial.
Lung Cancer
; 35(1): 1-7, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11750705
4.
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study).
Lung Cancer
; 77(1): 97-103, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22405570
Resultados
1 -
4
de 4
1
Próxima >
>>